(Q33489974)

27 July 2017

title

A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia (English)

1 reference

27 July 2017

main subject

phase I clinical trial

0 references

phase II clinical trial

0 references

author name string

Schrezenmeier H

1

1 reference

27 July 2017

Marsh JC

2

1 reference

27 July 2017

Stromeyer P

3

1 reference

27 July 2017

Müller H

4

1 reference

27 July 2017

Heimpel H

5

1 reference

27 July 2017

Gordon-Smith EC

6

1 reference

27 July 2017

Raghavachar A

7

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

British Journal of Haematology

27 July 2017

published in

1 reference

27 July 2017

volume

90

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

283-292

1 reference

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Biological and clinical aspects of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Hope for treatment of thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1995.TB05148.X

10.1111/J.1365-2141.1995.TB05148.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference